Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
6/20/2025
CDE Solicits Comments on the Draft ICH Guideline E21: Inclusion of P...
6/20/2025
CDE Issues the Technical Guidelines for IVRT and IVPT of Locally Actin...
6/20/2025
MindRank's Oral GLP-1RA MDR-001 Achieves Promising Phase IIb Results i...
6/20/2025
Simcere Gains Approval to Market Insomnia Drug Quviviq in China
6/20/2025
Lepu Begins MRG007 Trial in China, Licenses Global Rights to ArriVent
6/20/2025
CanSinoBIO Obtained NDA Approval for its 13-Valent Pneumococcal Polysa...
6/19/2025
China Set to Revive Biotech IPOs for Unprofitable Startups as Star Mar...
6/19/2025
China Becomes Testing Ground for Weight-Loss Drugs Despite Lower Obesi...
6/19/2025
Chinese Biopharma Firms Reroute Supply Chains and R\&D Amid Escalating...
6/19/2025
China's Biotech Boom Forces U.S. Pharma to Weigh Innovation Against Es...
6/19/2025
CDE Solicits Comments on the Application Dossier Requirements for Clin...
6/19/2025
CDE Solicits Comments on the Draft Technical Guidelines for Clinical R...
6/18/2025
GenMedicn Secures Series B Funding to Fuel Gene Therapy Pipeline for ...
6/18/2025
FDA Clears Boan Biotech to Advance Innovative CD228‑Targeting ADC BA1...
6/18/2025
EpimAb's HKEX IPO Application Accepted, Prospectus Now Published
6/18/2025
Abbisko Launches Pivotal Irpagratinib Trial Targeting FGFR4-Driven Liv...
6/17/2025
NMPA Holds Meeting to Review QMS in Vaccine Regulation, Pharma Manufa...
6/17/2025
Merck's Long-Acting RSV Antibody Clesrovimab Recommended for Priority ...
6/17/2025
BioTroy Thera Secures Over CNY 200M in Series A Financing
6/17/2025
Xiaolu Biomedicine Secures Tens of Mlns in Angel Funding Led by YuanB...
6/17/2025
SunRock Biopharma and Escugen Forge Alliance to Develop FIC CCR9-Targe...
6/16/2025
Lupin Partners with Sino Universal Pharma to Expand Access to Tiotropi...
6/16/2025
NMPA Seeks Comments on Initiative to Optimize Clinical Trial Review Pr...
6/16/2025
Teva, Fosun Pharma Partner to Develop Immuno-Oncology Therapy
6/16/2025
Merck's Keytruda Gains NMPA Approval in China for Advanced Liver Cance...
6/16/2025
Xuanzhu Prepares for HKSE Main Board Listing
6/16/2025
Legend Reportedly Disbands China Sales & Marketing Team Amid Shifts
6/16/2025
CARsgen Delivers Deep Responses with CT071 in Newly Diagnosed Multiple...
6/16/2025
Hengrui Presents Positive Phase 2 Obesity Data at ADA 2025
6/16/2025
NextCure and Simcere Zaiming Announce Strategic Partnership for a Nove...
Page:
3
/
53
Total number of articles:
1564
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit